Trial intelligence / Profile preview

Single-dose versus multiple-dose amoxicillin/clavulanic acid prophylaxis for caesarean section

PACTR202009483150226Completed

Sponsor
Sagir Muhammad
Start
Jul 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of amoxicillin + clavulanate in surgical site infection (SSI) and urinary tract infection (UTI) (2 arms), sponsored by Sagir Muhammad. Primary endpoint: Occurrence of surgical site infection. Started Jul 2019; status: completed.

02

Drugs

amoxicillin + clavulanate
03

Conditions

surgical site infection (SSI)urinary tract infection (UTI)

Beyond the preview

Go deeper on PACTR202009483150226.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202009483150226.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call